BRNX
BrenX Ltd.
There isn't enough reported data to score BRNX yet.
CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
BRNX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
BRNX's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BRNX PE Valuation
BRNX has no meaningful PE right now: it lost money over the past year.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
BRNX Forward outlook
There aren't enough analyst estimates for BRNX to show an outlook.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
BRNX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2020 | -$413.00 | +$155.05 |
| Q3 2020 | -$385.70 | +$160.30 |
| Q2 2020 | -$357.35 | +$171.15 |
| Q1 2020 | -$463.40 | -$10.85 |
| Q4 2019 | -$568.05 | -$186.55 |
| Q3 2019 | -$546.00 | -$185.15 |
| Q2 2019 | -$528.50 | -$193.55 |
| Q1 2019 | -$452.55 | +$25.55 |
CAT has the stronger earnings trend. Trailing diluted EPS is down 535% for BRNX versus CAT up 31%.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
BRNX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $20.5K | -99% |
| Q4 2022 | $1.5M | +2238% |
CAT has the stronger quarterly revenue trend. Revenue is down 100% for BRNX versus up 17% for CAT.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -1698% | +9436 points |
| Q4 2023 | -11134% | -6656 points |
| Q3 2023 | -11134% | -5983 points |
| Q4 2021 | -4478% | N/A |
| Q3 2021 | -5151% | N/A |
| Q2 2021 | -724% | N/A |
| Q4 2019 | -1730% | N/A |
| Q3 2019 | -1730% | N/A |
BRNX's operating margin was −1698% last quarter, up 3453 points from the same quarter a year ago.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
BRNX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$5.1M | +$517K |
| Q2 2025 | -$5.3M | -$1.4M |
| Q4 2024 | -$5.7M | -$3.4M |
| Q2 2024 | -$3.9M | -$867K |
| Q4 2023 | -$2.2M | +$7.9M |
| Q4 2022 | -$10.1M | -$7.9M |
| Q4 2021 | -$2.3M | -$877.9K |
| Q3 2021 | -$2M | -$611.9K |
CAT has the stronger cash trend. Its trailing FCF is up 39% versus its history, compared with BRNX at down 91%.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
BRNX Net Leverage
BRNX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
BRNX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.3 | Oversold |
| Stochastic | 0.3 | Oversold |
BRNX's weekly RSI is 24 (oversold) and its Stochastic is 0 (oversold).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BRNX PE vs Industrials Sector
BRNX has no meaningful PE right now: it lost money over the past year.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
BRNX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.08 | 60% below |
| 20 week MA | $2.62 | 84% below |
| 50 week MA | $34.4 | 99% below |
| 100 week MA | $447.0 | 100% below |
| 200 week MA | $3,255.0 | 100% below |
BRNX is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over BRNX on trend strength, trading above more of its moving averages.
BRNX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $35,910.0 | $16,065.0 | -55% |
| 2023 | $16,065.0 | $6,142.5 | -62% |
| 2024 | $6,142.5 | $1,071.0 | -83% |
| 2025 | $1,071.0 | $149.1 | -86% |
| 2026 YTD | $149.1 | $0.43 | -100% |
BRNX has finished every year since 2022 lower, and it's down 100% so far in 2026.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over BRNX on returns for 2026, with the stronger performance.